Commonwealth Equity Services’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-30,918
| Closed | -$1.43M | – | 2918 |
|
|
2019
Q2 | $1.43M | Sell |
30,918
-8,700
| -22% | -$244K | 0.01% | 1136 |
|
|
2019
Q1 | $965K | Buy |
39,618
+3,950
| +11% | +$82.2K | ﹤0.01% | 1321 |
|
|
2018
Q4 | $508K | Buy |
35,668
+5,743
| +19% | +$87.1K | ﹤0.01% | 1634 |
|
|
2018
Q3 | $454K | Buy |
29,925
+4,400
| +17% | +$67.4K | ﹤0.01% | 1848 |
|
|
2018
Q2 | $428K | Buy |
25,525
+870
| +4% | +$13.8K | ﹤0.01% | 1863 |
|
|
2018
Q1 | $402K | Sell |
24,655
-1,650
| -6% | -$26.4K | ﹤0.01% | 1861 |
|
|
2017
Q4 | $337K | Buy |
26,305
+500
| +2% | +$5.69K | ﹤0.01% | 1964 |
|
|
2017
Q3 | $317K | Buy |
25,805
+500
| +2% | +$4.64K | ﹤0.01% | 1939 |
|
|
2017
Q2 | $212K | Buy |
25,305
+320
| +1% | +$2.62K | ﹤0.01% | 2182 |
|
|
2017
Q1 | $223K | Sell |
24,985
-4,200
| -14% | -$44.7K | ﹤0.01% | 2069 |
|
|
2016
Q4 | $257K | Buy |
29,185
+400
| +1% | +$2.94K | ﹤0.01% | 1878 |
|
|
2016
Q3 | $194K | Buy |
28,785
+750
| +3% | +$2.9K | ﹤0.01% | 2000 |
|
|
2016
Q2 | $100K | Hold |
28,035
| – | – | ﹤0.01% | 2107 |
|
|
2016
Q1 | $83K | Buy |
28,035
+55
| +0.2% | +$165 | ﹤0.01% | 2086 |
|
|
2015
Q4 | $118K | Sell |
27,980
-2,000
| -7% | -$9.13K | ﹤0.01% | 2002 |
|
|
2015
Q3 | $137K | Buy |
29,980
+340
| +1% | +$2.02K | ﹤0.01% | 1927 |
|
|
2015
Q2 | $214K | Buy |
29,640
+3,000
| +11% | +$22.1K | ﹤0.01% | 1882 |
|
|
2015
Q1 | $196K | Buy |
26,640
+90
| +0.3% | +$641 | ﹤0.01% | 1934 |
|
|
2014
Q4 | $126K | Sell |
26,550
-1,300
| -5% | -$5.14K | ﹤0.01% | 1951 |
|
|
2014
Q3 | $99K | Buy |
27,850
+17,300
| +164% | +$68.2K | ﹤0.01% | 1961 |
|
|
2014
Q2 | $48K | Buy |
+10,550
| New | +$43.6K | ﹤0.01% | 1991 |
|
Other funds holding ARRY
Commonwealth Equity Services's ARRY Position: Q3 2019 in Review
Commonwealth Equity Services sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 30,918 shares — an estimated $1.43M sold.
Commonwealth Equity Services first reported a position in ARRY in Q2 2014 and held it in 21 quarters. The position peaked at $1.43M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Commonwealth Equity Services reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Commonwealth Equity Services sold 30,918 Array Biopharma Inc shares in Q3 2019, an estimated $1.43M.
- Commonwealth Equity Services first reported a position in Array Biopharma Inc in Q2 2014 and held it in 21 quarters.
- Commonwealth Equity Services's Array Biopharma Inc position peaked at $1.43M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Commonwealth Equity Services's 13F filing for Q3 2019, filed 30 Oct 2019.